FDA granted Fast Track designation while PTC Therapeutics and Eli Lilly acquired assets from Sangamo Therapeutics.

The entities involved

• FDA →
  • Hair banking, a hair restoration technique, has not yet received clearance from the FDA.22:32
  • FDA approved a drug based on UVA research led by Xuemei Huang.21:26
• Eli Lilly and Company →

  American pharmaceutical company

  • Kura Oncology created Caspian Therapeutics for diabetes research, which is backed by Eli Lilly, with a meeting scheduled in Milan.14:05
  • Bank of America and Citigroup issued buy ratings and raised price targets on July 18, 2026.07:52

Related events

• FDA granted Fast Track designation to NRX-100 on September 4, 2025.Jun 7
• Eli Lilly and Company announced agreements to acquire potential targets, filing reports with the SEC.Jun 7
• Eli Lilly and Company plans to submit a drug candidate to the FDA for review and approval.Aug 5
• Ligand Pharmaceuticals received FDA approval for its drug Filspari and was listed on the Nasdaq stock exchange.Sep 4
• Arise is seeking FDA approval for a drug as of October 7, 2026.Wed 14:38